I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 26% ± 10% | |
| CD8-positive, alpha-beta T cell | 10 studies | 20% ± 5% | |
| regulatory T cell | 10 studies | 19% ± 5% | |
| glutamatergic neuron | 9 studies | 46% ± 23% | |
| epithelial cell | 9 studies | 34% ± 13% | |
| GABAergic neuron | 7 studies | 38% ± 19% | |
| basal cell | 7 studies | 28% ± 15% | |
| natural killer cell | 6 studies | 22% ± 6% | |
| CD4-positive, alpha-beta T cell | 6 studies | 23% ± 7% | |
| neuron | 6 studies | 33% ± 12% | |
| interneuron | 6 studies | 36% ± 19% | |
| retinal rod cell | 6 studies | 27% ± 5% | |
| hematopoietic precursor cell | 5 studies | 29% ± 18% | |
| oligodendrocyte precursor cell | 5 studies | 24% ± 8% | |
| astrocyte | 5 studies | 27% ± 6% | |
| ciliated cell | 4 studies | 29% ± 16% | |
| effector CD8-positive, alpha-beta T cell | 4 studies | 23% ± 7% | |
| fibroblast | 4 studies | 17% ± 1% | |
| goblet cell | 4 studies | 26% ± 13% | |
| T cell | 4 studies | 17% ± 2% | |
| transit amplifying cell | 4 studies | 32% ± 16% | |
| oligodendrocyte | 4 studies | 24% ± 6% | |
| plasmablast | 3 studies | 46% ± 13% | |
| neutrophil | 3 studies | 28% ± 6% | |
| secretory cell | 3 studies | 34% ± 16% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 0% | |
| plasma cell | 3 studies | 30% ± 12% | |
| lymphocyte | 3 studies | 22% ± 4% | |
| memory B cell | 3 studies | 18% ± 3% | |
| hepatocyte | 3 studies | 45% ± 23% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 32% ± 17% | |
| enteroendocrine cell | 3 studies | 17% ± 0% | |
| intestinal crypt stem cell | 3 studies | 30% ± 4% | |
| club cell | 3 studies | 19% ± 2% | |
| macrophage | 3 studies | 16% ± 1% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 18% ± 1% |
